CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing small molecule activators of the NLRP3 inflammasome as potential immunostimulators. It aims to assess their effectiveness in treating cancer and enhancing immune responses through testing and market analysis to establish commercial viability.
We have identified a novel family of potent small molecule activators of the NLRP3 inflammasome.
The goal of this project is to determine the feasibility of developing these new immunostimulators into an attractive commercial proposition.
Establishment of technical feasibility will involve identification the most promising modifications of our drug candidates and testing their efficacy in disease models of cancer and immunization.
In addition, we will determine commercial feasibility by conducti…
UNIVERSITAETSKLINIKUM FREIBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
